In summary, we sought to elucidate reproducible, non-invasive, surrogate biomarkers in the Cln3Δex7/8 mouse model of CLN3-Batten disease that could potentially be translated to human patients. This evidence concerns the gene CLN3 and juvenile neuronal ceroid lipofuscinosis.